MedTrace Logo

Antibiotic Prophylaxis in Open Fractures

NCT02937181 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-10-28

No results posted yet for this study

Summary

Prospective look at antibiotic prophylaxis with Ceftaroline in patients with type II and III open fractures

Conditions

  • Open Fractures

Interventions

DRUG

Ceftaroline

IV Ceftaroline will be given for 72 hours

Sponsors & Collaborators

  • Forest Laboratories

    collaborator INDUSTRY

  • Olayemi Osiyemi MD

    lead OTHER

Principal Investigators

  • Olayemi Osiyemi, MD · Triple O Research Institute PA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-10-31
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02937181 on ClinicalTrials.gov